Belite Bio to Participate in Four Upcoming Investor Conferences

Rhea-AI Summary

Belite Bio (NASDAQ: BLTE) will participate in four investor conferences between April 28 and May 26, 2026, including Deutsche Bank ADR Virtual, BofA Securities Health Care, H.C. Wainwright BioConnect Nasdaq, and Stifel Virtual Ophthalmology Forum.

Webcasts are available under Events on the company investor site and replays will be archived for 90 days after each presentation.

News Market Reaction – BLTE

-1.77%

-1.77% Session close to close

In the Apr 23 session, BLTE declined 1.77%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the Company will participate in four upcoming investor conferences. Details of the presentations are as follows:  

• Deutsche Bank American Depositary Receipt Virtual Investor Conference (Virtual)
  • April 28, 2026, at 9:00 am ET, corporate presentation
• BofA Securities 2026 Health Care Conference (Las Vegas, NV)
  • May 13, 2026, at 3:40 pm PT, fireside chat
• H.C. Wainwright 4^th Annual BioConnect Nasdaq Investor Conference (New York, NY)
  • May 19, 2026, at 5:00 pm ET, fireside chat
• Stifel 2026 Virtual Ophthalmology Forum (Virtual)
  • May 26, 2026, at 12:30 pm ET, fireside chat

Webcast Link Instructions
Webcasts of the presentations can be accessed under "Events" in the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replays will be archived for 90 days following the presentation date.

About Belite Bio
Belite Bio is a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical need, such as Stargardt disease type 1 (STGD1) and geographic atrophy (GA) in advanced dry age-related macular degeneration (AMD), in addition to specific metabolic diseases. Belite Bio’s lead candidate, tinlarebant, is an oral therapy intended to reduce the accumulation of bisretinoid toxins in the eye. The Company has completed a Phase 3 trial (DRAGON) in adolescent STGD1 subjects, and the drug is currently being evaluated in a Phase 2/3 trial (DRAGON II) in adolescent STGD1 subjects and a Phase 3 trial (PHOENIX) in subjects with GA. For more information, follow us on X, Instagram, LinkedIn, and Facebook, or visit us at www.belitebio.com.

Media and Investor Relations Contacts:
Jennifer Wu / ir@belitebio.com
Argot Partners / belite@argotpartners.com 

FAQ

When will Belite Bio (BLTE) present at the Deutsche Bank ADR Virtual Investor Conference?

Belite Bio will present on April 28, 2026 at 9:00 am ET. According to the company, this is a corporate presentation and will be available via webcast on the company's Events page with a replay archived for 90 days.

What is the schedule for Belite Bio (BLTE) at the BofA Securities 2026 Health Care Conference?

Belite Bio is scheduled for a fireside chat on May 13, 2026 at 3:40 pm PT. According to the company, the session will be webcast and the replay will remain archived on the investor Events page for 90 days.

How can investors watch Belite Bio's (BLTE) May 19, 2026 Nasdaq investor conference presentation?

The May 19, 2026 fireside chat is at 5:00 pm ET and accessible via webcast. According to the company, visit the Events section on the investor website to join live or view the replay for up to 90 days after the presentation.

When is Belite Bio (BLTE) presenting at the Stifel 2026 Virtual Ophthalmology Forum?

Belite Bio will present on May 26, 2026 at 12:30 pm ET as a fireside chat. According to the company, the virtual session will be webcast with a replay available in the Events archive for 90 days.

Where can I find Belite Bio (BLTE) webcast links and replay access for the April–May 2026 conferences?

Webcast links and replay access are posted under Events in Belite Bio's investor relations site. According to the company, replays will be archived for 90 days following each presentation date.

Will Belite Bio (BLTE) archive replays of its investor conference presentations, and for how long?

Yes. According to the company, each presentation replay will be archived for 90 days after the presentation date and can be accessed via the Events page on the investor website.